CARNITOR SF Drug Patent Profile
✉ Email this page to a colleague
When do Carnitor Sf patents expire, and when can generic versions of Carnitor Sf launch?
Carnitor Sf is a drug marketed by Leadiant Biosci Inc and is included in one NDA.
The generic ingredient in CARNITOR SF is levocarnitine. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the levocarnitine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carnitor Sf
A generic version of CARNITOR SF was approved as levocarnitine by HIKMA on March 29th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARNITOR SF?
- What are the global sales for CARNITOR SF?
- What is Average Wholesale Price for CARNITOR SF?
Summary for CARNITOR SF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Clinical Trials: | 7 |
| Patent Applications: | 3,608 |
| Drug Prices: | Drug price information for CARNITOR SF |
| What excipients (inactive ingredients) are in CARNITOR SF? | CARNITOR SF excipients list |
| DailyMed Link: | CARNITOR SF at DailyMed |
Recent Clinical Trials for CARNITOR SF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 3 |
| National Cancer Institute (NCI) | Phase 2 |
| M.D. Anderson Cancer Center | Phase 2 |
Pharmacology for CARNITOR SF
| Drug Class | Carnitine Analog |
US Patents and Regulatory Information for CARNITOR SF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CARNITOR SF | levocarnitine | SOLUTION;ORAL | 019257-002 | Mar 28, 2007 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
